RxDoctor Payments Data

Derek Pride

Family Medicine · Myrtle Beach, SCNPI 1952938847

Payments from drug & device makers

$1,007in general payments, 2019–2025

Across 52 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$284
  • UCB, Inc.$242
  • Amgen$177
  • AbbVie$154
  • Averitas Pharma Inc.$35
  • Recordati_rare_diseases_inc.$29
  • plus $87 from 5 others

What the payments were for

  • Food & beverage$1,007100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,007 in reported general payments places this provider in the 60th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$342,440
Medicare patients
421
Services billed
7,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$91,532
EliquisApixaban50$56,456
FarxigaDapagliflozin Propanediol49$56,026
Repatha SureclickEvolocumab48$38,661
XareltoRivaroxaban13$18,942
MyrbetriqMirabegron12$14,584
MounjaroTirzepatide12$13,027
Tresiba Flextouch U-100Insulin Degludec11$9,297
SymbicortBudesonide/Formoterol Fumarate11$6,644
Atorvastatin Calcium551$5,253
Ezetimibe166$4,472
Azelastine Hcl107$4,129
Fluticasone Propionate221$4,024
SynthroidLevothyroxine Sodium30$3,154
Rosuvastatin Calcium202$3,095

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$284$91,53257 claims
AstraZenecaFarxiga, Symbicort$14$62,67060 claims
Lilly USA, LLCMounjaro$15$13,02712 claims
AbbVieSynthroid$154$3,15430 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →